12:00 AM
 | 
Nov 11, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Cumberland, Pernix Therapeutics sales and marketing update

The companies will co-promote Pernix's Omeclamox-Pak in the U.S. to treat Helicobacter pylori infection and duodenal ulcer disease in adults....

Read the full 89 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >